United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 26, 2026 · Filed Jun 29, 2026

On Jun 26, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$543.97 for US$5.17M under a trading plan, leaving 40,513 shares. Filed Jun 29, 2026 (Form 4).

Sold
9,500 shares
Price
US$543.97 average (US$538.34 to US$553.49)
Value
US$5.17M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jun 26, 2026Common StockSale640US$538.3449,373Direct
Jun 26, 2026Common StockSale1,018US$539.8948,355Direct
Jun 26, 2026Common StockSale2,128US$541.2446,227Direct
Jun 26, 2026Common StockSale983US$542.1445,244Direct
Jun 26, 2026Common StockSale1,012US$543.3244,232Direct
Jun 26, 2026Common StockSale439US$544.1843,793Direct
Jun 26, 2026Common StockSale560US$545.5243,233Direct
Jun 26, 2026Common StockSale156US$547.0043,077Direct
Jun 26, 2026Common StockSale452US$548.1342,625Direct
Jun 26, 2026Common StockSale872US$548.9041,753Direct
Jun 26, 2026Common StockSale520US$549.6941,233Direct
Jun 26, 2026Common StockSale400US$550.7940,833Direct
Jun 26, 2026Common StockSale280US$552.3640,553Direct
Jun 26, 2026Common StockSale40US$553.4940,513Direct

Source

View original at SEC

Related